Literature DB >> 2656078

Mechanisms of tissue damage by the membrane attack complex of complement.

B P Morgan1.   

Abstract

This article explores the role of the cytolytic membrane attack complex of complement in the pathogenesis of inflammatory diseases. Evidence of nucleated cell resistance to lysis by the membrane attack complex and the stimulation of secretion of pro-inflammatory factors in the absence of cell death in a variety of cell types in vitro are documented, and the possible significance of these non-lethal effects to the pathogenesis of inflammatory diseases highlighted.

Mesh:

Substances:

Year:  1989        PMID: 2656078     DOI: 10.1159/000463082

Source DB:  PubMed          Journal:  Complement Inflamm        ISSN: 1012-8204


  9 in total

1.  CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.

Authors:  Imre Farkas; Lajos Baranyi; Yasushige Ishikawa; Noriko Okada; Csaba Bohata; Denes Budai; Atsuo Fukuda; Masaki Imai; Hidechika Okada
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

2.  Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.

Authors:  G Triolo; E Giardina; D Casiglia; G Scarantino; G D Bompiani
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

3.  Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.

Authors:  R H Daniels; B D Williams; B P Morgan
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

Review 4.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

5.  Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Authors:  Claire L Harris; S Melanie Hanna; Masashi Mizuno; Dewi S Holt; Kevin J Marchbank; B Paul Morgan
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

6.  Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack.

Authors:  R H Daniels; W A Houston; M M Petersen; J D Williams; B D Williams; B P Morgan
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

7.  Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.

Authors:  D A Oleesky; R H Daniels; B D Williams; N Amos; B P Morgan
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

8.  Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex.

Authors:  K Høgåsen; T E Mollnes; P Brandtzaeg
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

Review 9.  New insights of an old defense system: structure, function, and clinical relevance of the complement system.

Authors:  Christian Ehrnthaller; Anita Ignatius; Florian Gebhard; Markus Huber-Lang
Journal:  Mol Med       Date:  2010-10-29       Impact factor: 6.354

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.